BIO-RAD LABORATORIES, INC. Insider Trading for September 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIO-RAD LABORATORIES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIO-RAD LABORATORIES, INC. for September 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | Hall Shannon | Executive Vice Pres ... | Sell | S | 221.20 | 1,245 | 275,390 | 565 | 1.8 K to 565 (-68.78 %) |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 159.32 | 1,600 | 254,912 | 6,400 | |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 139.56 | 1,600 | 223,296 | 4,800 | |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 119.54 | 1,200 | 143,448 | 2,400 | |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 117.00 | 640 | 74,880 | 640 | |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 107.32 | 650 | 69,758 | 0 | |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 220.47 | 1,388 | 306,012 | 66,473 | 67.9 K to 66.5 K (-2.05 %) |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 159.32 | 1,600 | 254,912 | 67,861 | 66.3 K to 67.9 K (+2.41 %) |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 220.47 | 1,320 | 291,020 | 66,261 | 67.6 K to 66.3 K (-1.95 %) |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 139.56 | 1,600 | 223,296 | 67,581 | 66 K to 67.6 K (+2.42 %) |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 220.47 | 938 | 206,801 | 65,981 | 66.9 K to 66 K (-1.40 %) |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 119.54 | 1,200 | 143,448 | 66,919 | 65.7 K to 66.9 K (+1.83 %) |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 220.47 | 497 | 109,574 | 65,719 | 66.2 K to 65.7 K (-0.75 %) |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 117.00 | 640 | 74,880 | 66,216 | 65.6 K to 66.2 K (+0.98 %) |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 220.47 | 491 | 108,251 | 65,576 | 66.1 K to 65.6 K (-0.74 %) |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 107.32 | 650 | 69,758 | 66,067 | 65.4 K to 66.1 K (+0.99 %) |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Option Exercise | M | 0.00 | 200 | 0 | 0 | |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Payment of Exercise | F | 218.04 | 76 | 16,571 | 6,683 | 6.8 K to 6.7 K (-1.12 %) |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Buy | M | 0.00 | 200 | 0 | 6,759 | 6.6 K to 6.8 K (+3.05 %) |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 2,617 | 0 | 0 | |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 218.04 | 1,366 | 297,843 | 242,865 | 244.2 K to 242.9 K (-0.56 %) |
Sep 14 2017 | BIO | BIO RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 0.00 | 2,617 | 0 | 244,231 | 241.6 K to 244.2 K (+1.08 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | Hall Shannon | Executive Vice Pres ... | Option Exercise | M | 0.00 | 240 | 0 | 0 | |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | Hall Shannon | Executive Vice Pres ... | Payment of Exercise | F | 218.04 | 91 | 19,842 | 1,810 | 1.9 K to 1.8 K (-4.79 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | Hall Shannon | Executive Vice Pres ... | Buy | M | 0.00 | 240 | 0 | 1,901 | 1.7 K to 1.9 K (+14.45 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 0 | |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Payment of Exercise | F | 218.04 | 226 | 49,277 | 12,562 | 12.8 K to 12.6 K (-1.77 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Buy | M | 0.00 | 600 | 0 | 12,788 | 12.2 K to 12.8 K (+4.92 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 300 | 0 | 0 | |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 218.04 | 157 | 34,232 | 65,417 | 65.6 K to 65.4 K (-0.24 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 0.00 | 300 | 0 | 65,574 | 65.3 K to 65.6 K (+0.46 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 240 | 0 | 0 | |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 500 | 0 | 1,500 | |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 240 | 0 | 240 | |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 218.04 | 91 | 19,842 | 11,651 | 11.7 K to 11.7 K (-0.77 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 0.00 | 240 | 0 | 11,742 | 11.5 K to 11.7 K (+2.09 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 218.86 | 279 | 61,062 | 11,502 | 11.8 K to 11.5 K (-2.37 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 0.00 | 740 | 0 | 11,781 | 11 K to 11.8 K (+6.70 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | M | 0.00 | 140 | 0 | 0 | |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | M | 0.00 | 150 | 0 | 450 | |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | M | 0.00 | 150 | 0 | 150 | |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Payment of Exercise | F | 218.04 | 53 | 11,556 | 3,449 | 3.5 K to 3.4 K (-1.51 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Buy | M | 0.00 | 140 | 0 | 3,502 | 3.4 K to 3.5 K (+4.16 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Payment of Exercise | F | 218.86 | 114 | 24,950 | 3,362 | 3.5 K to 3.4 K (-3.28 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Buy | M | 0.00 | 300 | 0 | 3,476 | 3.2 K to 3.5 K (+9.45 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 200 | 0 | 0 | |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 300 | 0 | 900 | |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 200 | 0 | 200 | |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Payment of Exercise | F | 218.04 | 76 | 16,571 | 746 | 822 to 746 (-9.25 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Buy | M | 0.00 | 200 | 0 | 822 | 622 to 822 (+32.15 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Payment of Exercise | F | 218.86 | 189 | 41,365 | 622 | 811 to 622 (-23.30 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Buy | M | 0.00 | 500 | 0 | 811 | 311 to 811 (+160.77 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | M | 0.00 | 334 | 0 | 0 | |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | M | 0.00 | 600 | 0 | 1,800 | |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | M | 0.00 | 376 | 0 | 376 | |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Payment of Exercise | F | 218.04 | 126 | 27,473 | 3,492 | 3.6 K to 3.5 K (-3.48 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Buy | M | 0.00 | 334 | 0 | 3,618 | 3.3 K to 3.6 K (+10.17 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Payment of Exercise | F | 218.86 | 368 | 80,540 | 3,284 | 3.7 K to 3.3 K (-10.08 %) |
Sep 13 2017 | BIO | BIO RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Buy | M | 0.00 | 976 | 0 | 3,652 | 2.7 K to 3.7 K (+36.47 %) |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Option Exercise | M | 0.00 | 500 | 0 | 1,500 | |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Option Exercise | M | 0.00 | 160 | 0 | 160 | |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Option Exercise | M | 0.00 | 400 | 0 | 800 | |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Payment of Exercise | F | 218.86 | 249 | 54,496 | 6,559 | 6.8 K to 6.6 K (-3.66 %) |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Buy | M | 0.00 | 660 | 0 | 6,808 | 6.1 K to 6.8 K (+10.74 %) |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Payment of Exercise | F | 218.42 | 151 | 32,981 | 6,148 | 6.3 K to 6.1 K (-2.40 %) |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Buy | M | 0.00 | 400 | 0 | 6,299 | 5.9 K to 6.3 K (+6.78 %) |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 3,200 | 0 | 9,600 | |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 2,600 | 0 | 2,600 | |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 2,000 | 0 | 4,000 | |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 218.86 | 3,027 | 662,489 | 241,614 | 244.6 K to 241.6 K (-1.24 %) |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 0.00 | 5,800 | 0 | 244,641 | 238.8 K to 244.6 K (+2.43 %) |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 218.42 | 1,044 | 228,030 | 238,841 | 239.9 K to 238.8 K (-0.44 %) |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 0.00 | 2,000 | 0 | 239,885 | 237.9 K to 239.9 K (+0.84 %) |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 1,800 | |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 0.00 | 700 | 0 | 700 | |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 1,200 | |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Payment of Exercise | F | 218.86 | 490 | 107,241 | 12,188 | 12.7 K to 12.2 K (-3.86 %) |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Buy | M | 0.00 | 1,300 | 0 | 12,678 | 11.4 K to 12.7 K (+11.43 %) |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Payment of Exercise | F | 218.42 | 226 | 49,363 | 11,378 | 11.6 K to 11.4 K (-1.95 %) |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Buy | M | 0.00 | 600 | 0 | 11,604 | 11 K to 11.6 K (+5.45 %) |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | Hall Shannon | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 1,800 | |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | Hall Shannon | Executive Vice Pres ... | Option Exercise | M | 0.00 | 240 | 0 | 240 | |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | Hall Shannon | Executive Vice Pres ... | Option Exercise | M | 0.00 | 240 | 0 | 480 | |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | Hall Shannon | Executive Vice Pres ... | Payment of Exercise | F | 218.86 | 317 | 69,379 | 1,661 | 2 K to 1.7 K (-16.03 %) |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | Hall Shannon | Executive Vice Pres ... | Buy | M | 0.00 | 840 | 0 | 1,978 | 1.1 K to 2 K (+73.81 %) |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | Hall Shannon | Executive Vice Pres ... | Payment of Exercise | F | 218.42 | 91 | 19,876 | 1,138 | 1.2 K to 1.1 K (-7.40 %) |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | Hall Shannon | Executive Vice Pres ... | Buy | M | 0.00 | 240 | 0 | 1,229 | 989 to 1.2 K (+24.27 %) |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 1,600 | 0 | 4,800 | |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 300 | 0 | 300 | |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 1,200 | 0 | 2,400 | |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 218.86 | 992 | 217,109 | 65,274 | 66.3 K to 65.3 K (-1.50 %) |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 0.00 | 1,900 | 0 | 66,266 | 64.4 K to 66.3 K (+2.95 %) |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 218.42 | 627 | 136,949 | 64,366 | 65 K to 64.4 K (-0.96 %) |
Sep 12 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 0.00 | 1,200 | 0 | 64,993 | 63.8 K to 65 K (+1.88 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 200 | 0 | 400 | |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 300 | 0 | 1,200 | |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Payment of Exercise | F | 218.42 | 76 | 16,600 | 311 | 387 to 311 (-19.64 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Buy | M | 0.00 | 200 | 0 | 387 | 187 to 387 (+106.95 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Payment of Exercise | F | 215.44 | 113 | 24,345 | 187 | 300 to 187 (-37.67 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Buy | M | 0.00 | 300 | 0 | 300 | 0 to 300 |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Option Exercise | M | 0.00 | 500 | 0 | 2,000 | |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Payment of Exercise | F | 215.44 | 188 | 40,503 | 5,899 | 6.1 K to 5.9 K (-3.09 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Buy | M | 0.00 | 500 | 0 | 6,087 | 5.6 K to 6.1 K (+8.95 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 3,000 | 0 | 12,000 | |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 215.25 | 1,566 | 337,082 | 237,885 | 239.5 K to 237.9 K (-0.65 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 0.00 | 3,000 | 0 | 239,451 | 236.5 K to 239.5 K (+1.27 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 400 | 0 | 800 | |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 400 | 0 | 1,600 | |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 218.42 | 151 | 32,981 | 11,041 | 11.2 K to 11 K (-1.35 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 0.00 | 400 | 0 | 11,192 | 10.8 K to 11.2 K (+3.71 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 218.42 | 151 | 32,981 | 10,792 | 10.9 K to 10.8 K (-1.38 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 0.00 | 400 | 0 | 10,943 | 10.5 K to 10.9 K (+3.79 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | M | 0.00 | 150 | 0 | 300 | |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | M | 0.00 | 170 | 0 | 680 | |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Payment of Exercise | F | 218.42 | 57 | 12,450 | 3,176 | 3.2 K to 3.2 K (-1.76 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Buy | M | 0.00 | 150 | 0 | 3,233 | 3.1 K to 3.2 K (+4.87 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Payment of Exercise | F | 215.44 | 64 | 13,788 | 3,083 | 3.1 K to 3.1 K (-2.03 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Buy | M | 0.00 | 170 | 0 | 3,147 | 3 K to 3.1 K (+5.71 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 2,400 | |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Payment of Exercise | F | 215.44 | 226 | 48,689 | 11,004 | 11.2 K to 11 K (-2.01 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Buy | M | 0.00 | 600 | 0 | 11,230 | 10.6 K to 11.2 K (+5.64 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | Hall Shannon | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 2,400 | |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | Hall Shannon | Executive Vice Pres ... | Payment of Exercise | F | 215.44 | 226 | 48,689 | 989 | 1.2 K to 989 (-18.60 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | Hall Shannon | Executive Vice Pres ... | Buy | M | 0.00 | 600 | 0 | 1,215 | 615 to 1.2 K (+97.56 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 1,600 | 0 | 6,400 | |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Payment of Exercise | F | 215.44 | 835 | 179,892 | 63,793 | 64.6 K to 63.8 K (-1.29 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Buy | M | 0.00 | 1,600 | 0 | 64,628 | 63 K to 64.6 K (+2.54 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Option Exercise | M | 0.00 | 500 | 0 | 2,000 | |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Payment of Exercise | F | 218.00 | 188 | 40,984 | 443 | 631 to 443 (-29.79 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Buy | M | 0.00 | 500 | 0 | 631 | 131 to 631 (+381.68 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | M | 0.00 | 389 | 0 | 778 | |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | M | 0.00 | 600 | 0 | 2,400 | |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Payment of Exercise | F | 218.42 | 147 | 32,108 | 2,676 | 2.8 K to 2.7 K (-5.21 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Buy | M | 0.00 | 389 | 0 | 2,823 | 2.4 K to 2.8 K (+15.98 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Payment of Exercise | F | 215.44 | 226 | 48,689 | 2,434 | 2.7 K to 2.4 K (-8.50 %) |
Sep 11 2017 | BIO | BIO RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Buy | M | 0.00 | 600 | 0 | 2,660 | 2.1 K to 2.7 K (+29.13 %) |
Sep 06 2017 | BIO | BIO RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Option Exercise | A | 215.98 | 3,000 | 647,940 | 3,000 | |
Sep 06 2017 | BIO | BIO RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
Sep 06 2017 | BIO | BIO RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Option Exercise | A | 0.00 | 1,500 | 0 | 1,500 | |
Sep 06 2017 | BIO | BIO RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | A | 215.98 | 13,000 | 2,807,740 | 13,000 | |
Sep 06 2017 | BIO | BIO RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | A | 0.00 | 13,000 | 0 | 13,000 | |
Sep 06 2017 | BIO | BIO RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | A | 215.98 | 2,500 | 539,950 | 2,500 | |
Sep 06 2017 | BIO | BIO RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
Sep 06 2017 | BIO | BIO RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | A | 0.00 | 900 | 0 | 900 | |
Sep 06 2017 | BIO | BIO RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | A | 215.98 | 3,000 | 647,940 | 3,000 | |
Sep 06 2017 | BIO | BIO RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
Sep 06 2017 | BIO | BIO RAD LABORATORI ... | Hall Shannon | Executive Vice Pres ... | Option Exercise | A | 215.98 | 3,000 | 647,940 | 3,000 | |
Sep 06 2017 | BIO | BIO RAD LABORATORI ... | Hall Shannon | Executive Vice Pres ... | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
Sep 06 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | A | 215.98 | 8,000 | 1,727,840 | 8,000 | |
Sep 06 2017 | BIO | BIO RAD LABORATORI ... | GOETZ JOHN | EVP, Chief Operatin ... | Option Exercise | A | 0.00 | 8,000 | 0 | 8,000 | |
Sep 06 2017 | BIO | BIO RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Option Exercise | A | 215.98 | 2,500 | 539,950 | 2,500 | |
Sep 06 2017 | BIO | BIO RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
Sep 06 2017 | BIO | BIO RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | A | 215.98 | 3,000 | 647,940 | 3,000 | |
Sep 06 2017 | BIO | BIO RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 |